Volume 12 Issue 1
Jan.  2021
Turn off MathJax
Article Contents
Ouyang Qing, Tan Xiaoyu, Huo Feng. Attaching importance to mechanical perfusion of donor liver and promoting high-quality development of liver transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 1-7. doi: 10.3969/j.issn.1674-7445.2021.01.001
Citation: Ouyang Qing, Tan Xiaoyu, Huo Feng. Attaching importance to mechanical perfusion of donor liver and promoting high-quality development of liver transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 1-7. doi: 10.3969/j.issn.1674-7445.2021.01.001

Attaching importance to mechanical perfusion of donor liver and promoting high-quality development of liver transplantation

doi: 10.3969/j.issn.1674-7445.2021.01.001
More Information
  • Corresponding author: Huo Feng, Email: gzhuofeng@163.com
  • Received Date: 2020-11-02
    Available Online: 2021-01-19
  • Publish Date: 2021-01-19
  • With the increasing quantity of organ donors and the continual expansion of the definition of extended criteria donor (ECD) livers, the quality of donor liver has become a prominent issue affecting the high-quality development of liver transplantation, which is also the study focus in related fields. Resolving the shortage of organs to the maximal extent and promoting the high-quality development of organ transplantation lead the development direction of organ donation and transplantation in China. In recent years, the application of mechanical perfusion (MP) for the perfusion, preservation, evaluation and repair of donor liver has become a hot topic to improve the quality of liver transplantation within the international community. In this article, according to different conditions of the application of ECD livers in liver transplantation at home and abroad in combination with the research progress on MP in the international community and relevant research experience of our center, the feasibility of establishing an organ intensive care unit (ICU) with integrated organ protection techniques was discussed, aiming to promote the high-quality development of organ transplantation in China and further expand the technical connotation of the "Chinese model" of organ donation and transplantation.

     

  • loading
  • [1]
    CZIGANY Z, TACKE F, LURJE G. Evolving trends in machine liver perfusion: comments on clinical end points and selection criteria[J]. Gastroenterology, 2019, 157(4):1166-1167. DOI: 10.1053/j.gastro.2019.02.051.
    [2]
    WHITE SL. Nudging the organ discard problem[J]. Transplantation, 2017, 101(7):1518-1519. DOI: 10.1097/TP.0000000000001718.
    [3]
    NAIR A, HASHIMOTO K. Extended criteria donors in liver transplantation-from marginality to mainstream[J]. Hepatobiliary Surg Nutr, 2018, 7(5):386-388. DOI: 10.21037/hbsn.2018.06.08.
    [4]
    GANDOLFINI I, BUZIO C, ZANELLI P, et al. The kidney donor profile index (KDPI) of marginal donors allocated by standardized pretransplant donor biopsy assessment: distribution and association with graft outcomes[J]. Am J Transplant, 2014, 14(11):2515-2525. DOI: 10.1111/ajt.12928.
    [5]
    FUDIM M, DAVIS ME, JENKINS C, et al. Marginal donor use in patients undergoing heart transplantation with left ventricular assist device explantation[J]. Ann Thorac Surg, 2015, 100(6):2117-2126. DOI: 10.1016/j.athoracsur.2015.05.110.
    [6]
    ADAM R, KARAM V, CAILLIEZ V, et al. 2018 Annual Report of the European Liver Transplant Registry (ELTR)-50-year evolution of liver transplantation[J]. Transpl Int, 2018, 31(12):1293-1317. DOI: 10.1111/tri.13358.
    [7]
    黄洁夫.中国器官移植发展报告(2015-2018)[R].昆明: 中国器官移植发展基金会, 2019.
    [8]
    CZIGANY Z, LURJE I, TOLBA RH, et al. Machine perfusion for liver transplantation in the era of marginal organs-new kids on the block[J]. Liver Int, 2019, 39(2):228-249. DOI: 10.1111/liv.13946.
    [9]
    HERRERO TORRES MA, DOMNIGUEZ BASTANTE M, MOLINA RAYA A, et al. Eight years of extracorporeal membrane oxygenation in liver transplantation: our experience[J]. Transplant Proc, 2020, 52(2):572-574. DOI: 10.1016/j.transproceed.2019.11.050.
    [10]
    HAGNESS M, FOSS S, SøRENSEN DW, et al. Liver transplant after normothermic regional perfusion from controlled donors after circulatory death: the Norwegian experience[J]. Transplant Proc, 2019, 51(2):475-478. DOI: 10.1016/j.transproceed.2019.01.066.
    [11]
    HESSHEIMER AJ, COLL E, TORRES F, et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation[J]. J Hepatol, 2019, 70(4):658-665. DOI: 10.1016/j.jhep.2018.12.013.
    [12]
    CHO Y, KIM C, KANG B. Risk of bias assessment of randomised controlled trials referenced in the 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care: a cross-sectional review[J]. BMJ Open, 2019, 9(5):e023725. DOI: 10.1136/bmjopen-2018-023725.
    [13]
    ZHANG Y, ZHANG Y, ZHANG M, et al. Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: a Meta-analysis[J]. Medicine (Baltimore), 2019, 98(23):e16033. DOI: 10.1097/MD.0000000000016033.
    [14]
    KRON P, SCHLEGEL A, MANCINA L, et al. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans[J]. J Hepatol, 2017, 68(1):82-91. DOI: 10.1016/j.jhep.2017.08.028.
    [15]
    THORNE AM, UBBINK R, BRÜGGENWIRTH IMA, et al. Hyperthermia-induced changes in liver physiology and metabolism: a rationale for hyperthermic machine perfusion[J]. Am J Physiol Gastrointest Liver Physiol, 2020, 319(1):G43-G50. DOI: 10.1152/ajpgi.00101.2020.
    [16]
    SCHLEGEL A, MULLER X, KALISVAART M, et al. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation[J]. J Hepatol, 2019, 70(1):50-57. DOI: 10.1016/j.jhep.2018.10.005.
    [17]
    MARTINS PN, BUCHWALD JE, MERGENTAL H, et al. The role of normothermic machine perfusion in liver transplantation[J]. Int J Surg, 2020, 82(Suppl):52-60. DOI: 10.1016/j.ijsu.2020.05.026.
    [18]
    NASRALLA D, COUSSIOS CC, MERGENTAL H, et al. A randomized trial of normothermic preservation in liver transplantation[J]. Nature, 2018, 557(7703):50-56. DOI: 10.1038/s41586-018-0047-9.
    [19]
    ESHMUMINOV D, BECKER D, BAUTISTA BORREGO L, et al. An integrated perfusion machine preserves injured human livers for 1 week[J]. Nat Biotechnol, 2020, 38(2):189-198. DOI: 10.1038/s41587-019-0374-x.
    [20]
    VON HORN C, BABA HA, HANNAERT P, et al. Controlled oxygenated rewarming up to normothermia for pretransplant reconditioning of liver grafts[J]. Clin Transplant, 2017, 31(11). DOI: 10.1111/ctr.13101.
    [21]
    DE VRIES Y, MATTON APM, NIJSTEN MWN, et al. Pretransplant sequential hypo- and normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution[J]. Am J Transplant, 2019, 19(4):1202-1211. DOI: 10.1111/ajt.15228.
    [22]
    DENGU F, ABBAS SH, EBELING G, et al. Normothermic machine perfusion (NMP) of the liver as a platform for therapeutic interventions during ex-vivo liver preservation: a review[J]. J Clin Med, 2020, 9(4):1046. DOI: 10.3390/jcm9041046.
    [23]
    FENG S, GOODRICH NP, BRAGG-GRESHAM JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index[J]. Am J Transplant, 2006, 6(4):783-790. DOI: 10.1111/j.1600-6143.2006.01242.x.
    [24]
    WINTER A, FÉRAY C, AUDUREAU E, et al. A donor quality index for liver transplantation: development, internal and external validation[J]. Sci Rep, 2018, 8(1): 9871. DOI: 10.1038/s41598-018-27960-7.
    [25]
    SCHLEGEL A, KALISVAART M, SCALERA I, et al. The UK DCD risk score: a new proposal to define futility in donation-after-circulatory-death liver transplantation[J]. J Hepatol, 2018, 68(3):456-464. DOI: 10.1016/j.jhep.2017.10.034.
    [26]
    DE MEIJER VE, FUJIYOSHI M, PORTE RJ. Ex situ machine perfusion strategies in liver transplantation[J]. J Hepatol, 2019, 70(1):203-205. DOI: 10.1016/j.jhep. 2018.09.019.
    [27]
    BHOGAL RH, MIRZA DF, AFFORD SC, et al. Biomarkers of liver injury during transplantation in an era of machine perfusion[J]. Int J Mol Sci, 2020, 21(5):1578. DOI: 10.3390/ijms21051578.
    [28]
    MATTON APM, DE VRIES Y, BURLAGE LC, et al. Biliary bicarbonate, pH, and glucose are suitable biomarkers of biliary viability during ex situ normothermic machine perfusion of human donor livers[J]. Transplantation, 2019, 103(7):1405-1413. DOI: 10.1097/TP.0000000000002500.
    [29]
    WATSON CJE, KOSMOLIAPTSIS V, PLEY C, et al. Observations on the ex situ perfusion of livers for transplantation[J]. Am J Transplant, 2018, 18(8):2005-2020. DOI: 10.1111/ajt.14687.
    [30]
    SCHREITER T, SOWA JP, SCHLATTJAN M, et al. Human ex-vivo liver model for acetaminophen-induced liver damage[J]. Sci Rep, 2016, 6:31916. DOI: 10.1038/srep31916.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (453) PDF downloads(73) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return